PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Facilitates Fast, Reproducible and Automatic Nitrogen Determination in Soil - Thermo Fisher Scientific facilitates fast, reproducible and automatic nitrogen determination in soils and plants (NYSE: TMO)
Thermo Fisher Scientific Facilitates Fast, Reproducible and Automatic Nitrogen Determination in Soil

 

NewswireToday - /newswire/ - Milan, Italy, 2010/07/28 - Thermo Fisher Scientific facilitates fast, reproducible and automatic nitrogen determination in soils and plants (NYSE: TMO).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thermo Fisher Scientific, Inc., the world leader in serving science, today announced a new application note for providing rapid, automatic and reproducible quantitative determination of nitrogen in soils and plants with the Thermo Scientific FLASH 4000 nitrogen/protein analyzer. The application note, entitled "Nitrogen Determination in Soils and Plants by the Thermo Scientific FLASH 4000 Elemental Analyzer," is available to download.

Nitrogen content in soils is an important evaluation parameter of organic matter. The analyses of nitrogen content provide valuable information regarding the deficiency or excess of nutritional elements important to plant growth. Nitrogen content analysis is also essential when determining the quality of various types of crops for feeding and processing, as well as for N-cycle and N-fixation monitoring in agricultural and environmental research.

For maximum analytical performance, nitrogen content determination in soils and plants must be performed using accurate instrumental analytical techniques while also avoiding the use of toxic chemicals. To achieve this, the classic Kjeldahl method has been replaced by the Dumas combustion method, a simple and automatic technique that does not require sample digestion of toxic chemicals and facilitates faster analysis combined with excellent reproducibility. The FLASH 4000 is based on the Dumas combustion method, providing significant advantages over the Kjeldahl method including laboratory staff safety, improved sample throughput, automation, reduced operational costs and quantitative determination of nitrogen in a large range of concentrations.

The new application note details the analytical configuration and analytical conditions required to achieve rapid, safe and reliable nitrogen content determination in soil and plant samples. The correct quantity of oxygen, correlated to the weight and type of sample, is determined automatically by the OxyTune feature of Thermo Scientific Eager Xperience software which facilitates the complete combustion of the sample.

Experimental results demonstrate excellent reproducibility and no memory effect when changing the type of sample, indicating the complete detection of the nitrogen present in the sample. The FLASH 4000 is able to analyze nitrogen in a wide range of samples from low to high content without matrix effects. In addition, the nitrogen data obtained using the analyzer is within the tolerable levels set by WEPAL International Round Robin Tests, demonstrating the high-performance of the instrument.

For more information about the Thermo Scientific FLASH 4000 nitrogen/protein analyzer, please call +1 800-532-4752, E: analyze[.]thermofisher.com.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. (thermoscientific.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Facilitates Fast, Reproducible and Automatic Nitrogen Determination in Soil

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Celine Callender - Scottpr.com 
+44 1477 539 539 thermo[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)